{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:22:35Z","timestamp":1789233755665,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.diabres.2025.113054","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:27:07Z","timestamp":1765592827000},"page":"113054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-1671","authenticated-orcid":false,"given":"Soo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimei","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jothydev","family":"Kesavadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Pik Shan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J","family":"McGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Yih","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kwan","family":"O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.113054_b0005","unstructured":"International Diabetes Foundation. IDF Diabetes Atlas, 11th Edition 2025 [cited 2025 September 04]. Available from: https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025."},{"key":"10.1016\/j.diabres.2025.113054_b0010","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S181-S206. doi: 10.2337\/dc25-S009.","DOI":"10.2337\/dc25-S009"},{"key":"10.1016\/j.diabres.2025.113054_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110718","article-title":"Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management","volume":"201","author":"Kong","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.113054_b0020","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes-2024. Diabetes Care. 2023;47(Supplement_1):S158-S78. doi: 10.2337\/dc24-S009.","DOI":"10.2337\/dc24-S009"},{"key":"10.1016\/j.diabres.2025.113054_b0025","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes technology: Standards of care in diabetes-2024. Diabetes Care. 2023;47(Supplement_1):S126-S44. doi: 10.2337\/dc24-S007.","DOI":"10.2337\/dc24-S007"},{"key":"10.1016\/j.diabres.2025.113054_b0030","doi-asserted-by":"crossref","unstructured":"Taylor PJ, Thompson CH, Brinkworth GD. Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review. Journal of Diabetes Investigation. 2018;9(4):713-25. Epub 2018\/03\/01. doi: 10.1111\/jdi.12807.","DOI":"10.1111\/jdi.12807"},{"key":"10.1016\/j.diabres.2025.113054_b0035","article-title":"Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary delphi consensus","author":"Mario","year":"2022","journal-title":"Research Square Platform LLC"},{"key":"10.1016\/j.diabres.2025.113054_b0040","doi-asserted-by":"crossref","unstructured":"Kesavadev J, Misra A, Saboo B, Agarwal S, Sosale A, Joshi SR, et al. Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia. Diabetes Metababolic Syndrome: Clinical Research and Reviews. 2022;16(1):102345. Epub 20211122. doi: 10.1016\/j.dsx.2021.102345.","DOI":"10.1016\/j.dsx.2021.102345"},{"key":"10.1016\/j.diabres.2025.113054_b0045","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes technology: Standards of care in diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S146-S66. doi: 10.2337\/dc25-S007.","DOI":"10.2337\/dc25-er04b"},{"key":"10.1016\/j.diabres.2025.113054_b0050","doi-asserted-by":"crossref","unstructured":"Jancev M, Vissers TACM, Visseren FLJ, van Bon AC, Sern\u00e9 EH, DeVries JH, et al. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia. 2024;67(5):798-810. Epub 20240216. doi: 10.1007\/s00125-024-06107-6.","DOI":"10.1007\/s00125-024-06107-6"},{"key":"10.1016\/j.diabres.2025.113054_b0055","doi-asserted-by":"crossref","unstructured":"Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Flash Glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes therapy. 2017;8(1):55-73. Epub 2016\/12\/20. doi: 10.1007\/s13300-016-0223-6.","DOI":"10.1007\/s13300-016-0223-6"},{"issue":"7","key":"10.1016\/j.diabres.2025.113054_b0060","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00125-024-06152-1","article-title":"Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial","volume":"67","author":"Kim","year":"2024","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.diabres.2025.113054_b0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/dc23-2194","article-title":"Comparing continuous glucose monitoring and blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes (Steno2tech study): a 12-month, single-center, randomized controlled trial","volume":"47","author":"Lind","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2025.113054_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc23-1520","article-title":"Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence","volume":"47","author":"Seidu","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.113054_b0075","doi-asserted-by":"crossref","unstructured":"Evans M, Welsh Z, Seibold A. Reductions in HbA1c with flash glucose monitoring are sustained for up to 24 months: a meta-analysis of 75 real-world observational studies. Diabetes Therapy. 2022;13(6):1175-85. Epub 2022\/04\/27. doi: 10.1007\/s13300-022-01253-9.","DOI":"10.1007\/s13300-022-01253-9"},{"key":"10.1016\/j.diabres.2025.113054_b0080","doi-asserted-by":"crossref","unstructured":"Roussel R, Riveline J-P, Vicaut E, de Pouvourville G, Detournay B, Emery C, et al. Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: The RELIEF study. Diabetes Care. 2021;44(6):1368-76. Epub 2021\/04\/20. doi: 10.2337\/dc20-1690.","DOI":"10.2337\/dc20-1690"},{"issue":"9","key":"10.1016\/j.diabres.2025.113054_b0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/dia.2022.0085","article-title":"Reduced rate of acute diabetes events with flash glucose monitoring is sustained for 2 years after initiation: Extended outcomes from the RELIEF study","volume":"24","author":"Riveline","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2025.113054_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00125-024-06289-z","article-title":"Intermittently scanned continuous glucosemonitoring compared with blood glucose monitoring is associated with lower HbA1cand a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies","volume":"68","author":"Nathanson","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.113054_b0095","doi-asserted-by":"crossref","unstructured":"Ehrhardt N, Al Zaghal E. Behavior modification in prediabetes and diabetes: Potential use of real-time continuous glucose monitoring. Journal of Diabetes Science and Technology. 2019;13(2):271-5. Epub 2018\/08\/01. doi: 10.1177\/1932296818790994.","DOI":"10.1177\/1932296818790994"},{"key":"10.1016\/j.diabres.2025.113054_b0100","doi-asserted-by":"crossref","unstructured":"Lee DY, Kim N, Jung I, Park SY, Yu JH, Seo JA, et al. Clinical and lifestyle determinants of continuous glucose monitoring metrics in insulin-treated patients with type 2 diabetes mellitus. Diabetes & Metabolism Journal. 2023;47(6):826-36. Epub 2023\/08\/24. doi: 10.4093\/dmj.2022.0273.","DOI":"10.4093\/dmj.2022.0273"},{"issue":"12","key":"10.1016\/j.diabres.2025.113054_b0105","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2337\/dc21-1304","article-title":"The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin","volume":"44","author":"Aleppo","year":"2021","journal-title":"Diabetes Care"},{"issue":"S1","key":"10.1016\/j.diabres.2025.113054_b0110","first-page":"S27","article-title":"Type 2 diabetes and the use of real-time continuous glucose monitoring","volume":"23","author":"Jackson","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.diabres.2025.113054_b0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/26350106251326517","article-title":"Intermittent use of continuous glucose monitoring in type 2 diabetes is preferred: a qualitative study of patients' experiences","volume":"51","author":"Bendixen","year":"2025","journal-title":"Sci Diabetes Self Manag Care"},{"issue":"9118","key":"10.1016\/j.diabres.2025.113054_b0120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.diabres.2025.113054_b0125","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.113054_b0130","doi-asserted-by":"crossref","unstructured":"de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, et al. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment. Kidney International. 2020;98(4):839-48. Epub 2020\/07\/10. doi: 10.1016\/j.kint.2020.06.024.","DOI":"10.1016\/j.kint.2020.06.024"},{"issue":"6865","key":"10.1016\/j.diabres.2025.113054_b0135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.diabres.2025.113054_b0140","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2202038","article-title":"Clinical overview of diabetes mellitus as a risk factor for cardiovascular death","volume":"22","author":"Abuelgasim","year":"2021","journal-title":"Rev Cardiovasc Med"},{"issue":"24","key":"10.1016\/j.diabres.2025.113054_b0145","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.115.015946","article-title":"Cardiovascular implications of hypoglycemia in diabetes mellitus","volume":"132","author":"Connelly","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.113054_b0150","doi-asserted-by":"crossref","unstructured":"G\u00e6de P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving H-H, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59(11):2298-307. Epub 2016\/08\/16. doi: 10.1007\/s00125-016-4065-6.","DOI":"10.1007\/s00125-016-4065-6"},{"issue":"6","key":"10.1016\/j.diabres.2025.113054_b0155","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/dom.13243","article-title":"Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?","volume":"20","author":"Khunti","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.113054_b0160","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: Standards of care in diabetes-2024. Diabetes Care. 2023;47(Supplement_1):S179-S218. doi: 10.2337\/dc24-S010.","DOI":"10.2337\/dc24-S010"},{"key":"10.1016\/j.diabres.2025.113054_b0165","doi-asserted-by":"crossref","unstructured":"FLAT-SUGAR Trial Investigators. Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus GLP-1 agonist in participants with type 2 diabetes at high cardiovascular risk. Diabetes Care. 2016;39(6):973-81. Epub 20160419. doi: 10.2337\/dc15-2782.","DOI":"10.2337\/dc15-2782"},{"key":"10.1016\/j.diabres.2025.113054_b0170","doi-asserted-by":"crossref","unstructured":"Tremamunno S, Tartaglione L, Telesca A, Rizzi A, Felici T, Mazzotta F, et al. Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: A comparison of cardiovascular effects. Endocrine. 2024;84(1):128-35. Epub 2024\/01\/10. doi: 10.1007\/s12020-023-03651-w.","DOI":"10.1007\/s12020-023-03651-w"},{"issue":"1","key":"10.1016\/j.diabres.2025.113054_b0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12933-021-01425-0","article-title":"Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study","volume":"20","author":"Andersen","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.diabres.2025.113054_b0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/dc22-1219","article-title":"Multicenter randomized trial of intermittently scanned continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes and recent-onset acute myocardial infarction: results of the LIBERATES Trial","volume":"46","author":"Ajjan","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2025.113054_b0185","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","article-title":"Continuous glucose monitoring for the routine care of type 2 diabetes mellitus","volume":"20","author":"Ajjan","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.diabres.2025.113054_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70059","article-title":"Enhancing type 2 diabetes care with cgm integration: Insights from an italian expert group","volume":"41","author":"Irace","year":"2025","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.diabres.2025.113054_b0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1900\/RDS.2022.18.100","article-title":"Asian best practices for care of diabetes in elderly (ABCDE)","volume":"18","author":"Kalra","year":"2022","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.diabres.2025.113054_b0200","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 13. Older adults: Standards of care in diabetes\u20142024. Diabetes Care. 2023;47(Supplement_1):S244-S57. doi: 10.2337\/dc24-S013.","DOI":"10.2337\/dc24-S013"},{"key":"10.1016\/j.diabres.2025.113054_b0205","doi-asserted-by":"crossref","unstructured":"Bao S, Bailey R, Calhoun P, Beck RW. Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin. Diabetes Technology & Therapeutics. 2022;24(5):299-306. Epub 2021\/12\/22. doi: 10.1089\/dia.2021.0494.","DOI":"10.1089\/dia.2021.0494"},{"issue":"11","key":"10.1016\/j.diabres.2025.113054_b0210","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2666-7568(21)00251-8","article-title":"Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study","volume":"2","author":"Fung","year":"2021","journal-title":"The Lancet Healthy Longevity"},{"issue":"1","key":"10.1016\/j.diabres.2025.113054_b0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002590","article-title":"Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis","volume":"10","author":"Carlson","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"10.1016\/j.diabres.2025.113054_b0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4093\/dmj.2017.0065","article-title":"Higher prevalence and progression rate of chronic kidney disease in elderly patients with type 2 diabetes mellitus","volume":"42","author":"Kim","year":"2018","journal-title":"Diabetes Metab J"},{"issue":"2","key":"10.1016\/j.diabres.2025.113054_b0225","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/jcm13020348","article-title":"Chronic kidney disease in the older adult patient with diabetes","volume":"13","author":"Ravender","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.diabres.2025.113054_b0230","first-page":"49","article-title":"Diabetic kidney disease: world wide difference of prevalence and risk factors","volume":"5","author":"Gheith","year":"2015","journal-title":"J Nephropharmacol"},{"issue":"3","key":"10.1016\/j.diabres.2025.113054_b0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/jfcm.JFCM_304_19","article-title":"Incidence and risk factors associated with hypoglycemia among patients with chronic kidney disease: a systematic review","volume":"27","author":"Aleissa","year":"2020","journal-title":"J Family Community Med"},{"key":"10.1016\/j.diabres.2025.113054_b0240","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5S):S1-S127. doi: 10.1016\/j.kint.2022.06.008.","DOI":"10.1016\/j.kint.2022.06.008"},{"issue":"8","key":"10.1016\/j.diabres.2025.113054_b0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00592-021-01699-6","article-title":"Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis","volume":"58","author":"Gallieni","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2025.113054_b0250","doi-asserted-by":"crossref","unstructured":"Twigg S, Lim S, Yoo S-H, Chen L, Bao Y, Kong A, et al. Asia-Pacific perspectives on the role of continuous glucose monitoring in optimizing diabetes management. Journal of Diabetes Science and Technology. 2024;18(6):1460-71. Epub 2023\/05\/26. doi: 10.1177\/19322968231176533.","DOI":"10.1177\/19322968231176533"},{"key":"10.1016\/j.diabres.2025.113054_b0255","doi-asserted-by":"crossref","unstructured":"Didyuk O, Econom N, Guardia A, Livingston K, Klueh U. Continuous glucose monitoring devices: Past, present, and future focus on the history and evolution of technological innovation. Journal of Diabetes Science and Technology. 2021;15(3):676-83. Epub 2020\/01\/13. doi: 10.1177\/1932296819899394.","DOI":"10.1177\/1932296819899394"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:42:11Z","timestamp":1779093731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725010691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"alternative-id":["S0168822725010691"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113054","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113054"}}